Emami Ltd (EMAMILTD) Q1 FY27 Results Analysis: EBITDA Grows 21%, Tax Rate Jumps to 29%

Emami Ltd's Q1 FY27 numbers came in soft, with revenue of Rs. 1,039.21 Cr (+14.95% YoY) and PAT growth of -15.41% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

Emami's standalone performance was strong with 21% EBITDA growth and 516bps margin expansion, but consolidated results were dragged by acquisition integration costs, a 10% decline in international business due to geopolitical disruption, and a sharp tax rate normalisation. The effective tax rate jump from 12% to 29% is structural and will continue to pressure PAT, while the near-term dilution from acquisitions clouds the earnings outlook.

Key Investment Insights

Key Positives

• Standalone EBITDA grew 21.28% YoY to Rs.268.62 Cr, with margin expanding 516 bps to 34.44%.
• India segment revenue increased 19.62% YoY to Rs.911.96 Cr, driven by summer portfolio recovery and acquisition contribution.
• Standalone PAT grew 11.73% YoY to Rs.182.22 Cr, with EPS of Rs.4.17 (+11.50% YoY).
• The company reported a net cash position of Rs.744.4 Cr at FY26-end, indicating a debt-light balance sheet.

Risk Factors

• Consolidated PAT attributable to owners declined 16.38% YoY to Rs.137.35 Cr, dragged by acquisition integration costs and tax normalisation.
• International business revenue declined 10.19% YoY, worse than management's guidance of 'close to single-digit growth', due to Strait of Hormuz disruption.
• Consolidated EBITDA margin contracted 254 bps YoY to 23.54%, driven by crude-linked input cost inflation (cost of materials +31.39% YoY).
• The effective tax rate surged from 12.05% to 28.64% due to the expiry of the Assam facility's 80IE tax holiday, impacting PAT.
• The auditor issued a qualified conclusion on consolidated results due to unreviewed subsidiaries.
• Acquisitions (Axiom Ayurveda, IncNut Digital) are near-term dilutive to consolidated PAT, contributing a drag of Rs.44.87 Cr.